Dongbang Medical Co., Ltd (KOSDAQ:240550)

Market Cap	212.68B
Revenue (ttm)	108.31B
Net Income (ttm)	9.33B
Shares Out	20.81M
EPS (ttm)	509.74
PE Ratio	20.05
Forward PE	9.47
Dividend	n/a
Ex-Dividend Date	n/a

Volume	165,194
Average Volume	122,411
Open	10,580
Previous Close	10,540
Day's Range	10,130 - 10,610
52-Week Range	9,100 - 15,490
Beta	n/a
RSI	36.60
Earnings Date	Nov 27, 2025

About Dongbang Medical

Dongbang Medical Co., Ltd produces and sells medical devices, fillers, bio medical devices, and cosmetics devices in South Korea. It offers HA filler, a medical device used for improving facial wrinkles and volume recovery under the ELASTY GRAND, ELASTY DEEP PLUS, ELASTY G PLUS, ELASTY D PLUS, and ELASTY F PLUS names; threads under the ELASTY LINE, ELASTY MESHFILL, ELASTY-V BARB, ELASTY-V UP, ELASTY-V SCREW, and ELASTY-V MONO names; and cannula, needle, and syringe products. The company also provides Hyaluronic acid mask, Beta-Glucan mask, FILL...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1985
• Employees: 282
• Stock Exchange: KOSDAQ
• Ticker Symbol: 240550

Financial Performance

In 2024, Dongbang Medical's revenue was 105.11 billion, an increase of 15.67% compared to the previous year's 90.88 billion. Earnings were 2.91 billion, a decrease of -70.19%.